Planned Seladelpar Phase 3 Study in Primary Biliary Cholangitis. a Tipping Point Analysis to Determine Failure Boundaries.

Amato, G; Hansen, BE; Hirschfield, G; Boudes, P; Rosen, A

HEPATOLOGY, 2018; 68 (): 1110A